4392-54-5 | 4-Hydrazinobenzenesulfonamide

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$15.00	$11.00
1g	98%	in stock	$47.00	$33.00

Description

• Catalog Number: AI50455
• Chemical Name: 4-Hydrazinobenzenesulfonamide
• CAS Number: 4392-54-5
• Molecular Formula: C6H9N3O2S
• Molecular Weight: 187.2196
• MDL Number: MFCD00625132
• SMILES: NNc1ccc(cc1)S(=O)(=O)N
• NSC Number: 73246

Computed Properties

• Complexity: 226
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 12
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 2
• XLogP3: -0.1

Literature

• Synthesis and antimicrobial evaluation of some pyrazole derivatives.

  Molecules (Basel, Switzerland) 20120430

• 2-(4-Sulfamoylphen-yl)hydrazin-1-ium chloride.

  Acta crystallographica. Section E, Structure reports online 20120401

• 4-[5-(Furan-2-yl)-3-trifluoro-methyl-1H-pyrazol-1-yl]benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20120401

• Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones.

  European journal of medicinal chemistry 20120301

• Cloning, characterization and sulfonamide inhibition studies of an α-carbonic anhydrase from the living fossil sponge Astrosclera willeyana.

  Bioorganic & medicinal chemistry 20120215

• Synthesis and biological evaluation of some novel sulfamoylphenyl-pyridazinone as anti-inflammatory agents (Part-II * ).

  Journal of enzyme inhibition and medicinal chemistry 20120201

• 4-(5-Phenyl-3-trifluoro-meth-yl-1H-pyrazol-1--yl)benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20110901

• 4-(3-Methyl-5-phenyl-1H-pyrazol-1-yl)benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20110901

• 4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20110901

• 4-(5-Oxo-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20110901

• 4-(3-Methyl-4,5-dihydro-1H-benzo[g]indazol-1-yl)benzene-sulfonamide.

  Acta crystallographica. Section E, Structure reports online 20110901

• Inhibition studies of the β-carbonic anhydrases from the bacterial pathogen Salmonella enterica serovar Typhimurium with sulfonamides and sulfamates.

  Bioorganic & medicinal chemistry 20110815

• A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth.

  Bioorganic & medicinal chemistry 20110201

• Synthesis and biological evaluation of some pyrazolylpyrazolines as anti-inflammatory-antimicrobial agents.

  European journal of medicinal chemistry 20100601

• 3D-QSAR study of benzene sulfonamide analogs as carbonic anhydrase II inhibitors.

  Bioorganic & medicinal chemistry letters 20100515

• Synthesis and biological evaluation of some novel 6-aryl-2-(p-sulfamylphenyl)-4,5-dihydropyridazin-3(2H)-ones as anti-cancer, antimicrobial, and anti-inflammatory agents.

  Journal of enzyme inhibition and medicinal chemistry 20100401

• Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.

  Journal of medicinal chemistry 20100311

• Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.

  Bioorganic & medicinal chemistry letters 20070701

• Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.

  Journal of medicinal chemistry 20070125

• Liquid-chromatographic separation and determination of process-related impurities, including a regio-specific isomer of celecoxib on reversed-phase C18 column dynamically coated with hexamethyldisilazane.

  Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20060901

• Carbonic anhydrase inhibitors: cloning and sulfonamide inhibition studies of a carboxyterminal truncated alpha-carbonic anhydrase from Helicobacter pylori.

  Bioorganic & medicinal chemistry letters 20060415

• QSAR study on topically acting sulfonamides incorporating GABA moieties: a molecular connectivity approach.

  Bioorganic & medicinal chemistry letters 20060401

• Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.

  Journal of medicinal chemistry 20060323

• Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.

  Journal of medicinal chemistry 20051201

• Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides.

  Bioorganic & medicinal chemistry letters 20050901

• Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.

  Bioorganic & medicinal chemistry letters 20050215

• Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.

  Bioorganic & medicinal chemistry letters 20050215

• Carbonic anhydrase inhibitors. Inhibition of the prokariotic beta and gamma-class enzymes from Archaea with sulfonamides.

  Bioorganic & medicinal chemistry letters 20041220

• Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.

  Bioorganic & medicinal chemistry letters 20041115

• Carbonic anhydrase inhibitors: the first QSAR study on inhibition of tumor-associated isoenzyme IX with aromatic and heterocyclic sulfonamides.

  Bioorganic & medicinal chemistry letters 20040621

• Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides.

  Bioorganic & medicinal chemistry letters 20030324

• Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.

  Journal of medicinal chemistry 20020328

• Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.

  Bioorganic & medicinal chemistry letters 20010226